Home|Journals|Articles by Year|Audio Abstracts

Mini Review

J App Pharm Sci. 2018; 8(10): 165-171

Synovium Targeting Delivery of TNFα Blocker for Rheumatoid Arthritis Therapy – A Mini Review

Riyona Desvy Pratiwi, Muhammad Novrizal Abdi Sahid.


Tumor necrosis factor α (TNFα) blockers are proven as potential suppressing agents on rheumatoid arthritis. Not only showing significant effects in clinical treatment, yet they are also known as top largest selling among the biological agents. However, several systemic side effects are shown after treatments with TNFα blockers which are related to infection and cancer. In order to reduce and overcome the side effects, a targeted delivery is then requested. Synovial membrane is considered as a promising delivery target because TNFα is highly accumulated therein. The current article reviewed a number of strategies that might be applied in the synovial membrane targeting for TNFα blocker.

Key words: rheumatoid arthritis, tumor necrosis factor α blocker, synovium, targeting delivery

Full-text options

Share this Article

Online Article Submission
• ejmanager.com

ejPort - eJManager.com
Refer & Earn
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.